Ledipasvir D-tartrate CAS 1502654-87-6
| CAS No. | 1502654-87-6 |
| Molecular Formula | C49H54F2N8O6 |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
Ledipasvir D-tartrate (CAS 1502654-87-6), molecular formula C49H54F2N8O6C4H6O6 and molecular weight 1039.10 g/mol, is a CATO reference standard with documented purity and traceability.
The molecular framework of Ledipasvir D-tartrate (C49H54F2N8O6C4H6O6) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
This reference standard is suitable for quantitative analysis on major chromatographic platforms including HPLC, GC, LC-MS/MS, and GC-MS, serving as an external calibration standard or a system suitability test reference material.
CATO manufactures Ledipasvir D-tartrate under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C49H54F2N8O6 C4H6O6 |
| Molecular Weight | 1039.10 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 27.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1992 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 8 |
Related Ledipasvir Standards
Recommended Standards
- 4-Chloro-3-(thiophene-2-amido)benzoic acid (CAS 379254-57-6)
- 6,7-Dibromo-1H-pyrrolo[3,2-d]pyrimidine-2,4(3H,5H)-dione (CAS 20419-75-4)
- Methyl 3-ethyl-1-methyl-1H-pyrazole-5-carboxylate (CAS 88398-74-7)
- (5,6-Dichloropyridin-3-yl)methanamine hydrochloride (CAS 1428532-85-7)
- Ethyl 3,5-dibromo-1H-1,2,4-triazole-1-carboxylate (CAS 1858251-62-3)
- Tert-butyl (s)-3-(2,2-dioxido-1,4-dihydro-3h-benzo[c][1,2,6]thiadiazin-3-yl)pyrrolidine-1-carboxylate (CAS 1389310-31-9)
- methyl 2-[(5-bromo-2-nitrophenyl)amino]-2-methylpropanoate (CAS 1803589-02-7)
- cis-3-(tert-Butyl)cyclobutan-1-ol (CAS 20588-76-5)
- Methyl 3-bromo-6-chloro-2-fluorobenzoate (CAS 1543224-54-9)
- D-[γ-Glu](Side Chain)-Semaglutide (CAS CATO-C4X-2226254)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com